Cargando…
Promising Perspective to Facioscapulohumeral Muscular Dystrophy Treatment: Nutraceuticals and Phytochemicals
Facioscapulohumeral Muscular Dystrophy (FSHD) is in the top three list of all dystrophies with an approximate 1:8000 incidence. It is not a life-threatening disease; however, the progression of the disease extends over being wheelchair bound. Despite some drug trials continuing, including DUX4 inhib...
Autores principales: | Hangül, Ceren, Karaüzüm, Sibel Berker, Akkol, Esra Küpeli, Demir-Dora, Devrim, Çetin, Zafer, Saygılı, Eyüp İlker, Evcili, Gökhan, Sobarzo-Sánchez, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185762/ https://www.ncbi.nlm.nih.gov/pubmed/34315378 http://dx.doi.org/10.2174/1570159X19666210726151924 |
Ejemplares similares
-
A Novel Coincidence: Essential Thrombocythemia with Facioscapulohumeral Muscular Dystrophy
por: Hangül, Ceren, et al.
Publicado: (2020) -
The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Hangül, Ceren, et al.
Publicado: (2019) -
Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease
por: Hangul, Ceren, et al.
Publicado: (2022) -
Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders
por: Karakan, Tarkan, et al.
Publicado: (2021) -
Phytochemical Composition and Biological Activities of Arctium minus (Hill) Bernh.: A Potential Candidate as Antioxidant, Enzyme Inhibitor, and Cytotoxic Agent
por: İlgün, Selen, et al.
Publicado: (2022)